Norris G. Turner
Norris G. Turner, PharmD, PhD, Principal, Turner Healthcare Quality (THCQ) Consulting LLC, is a Senior Advisor for Discern Health. Norris brings nearly 20 years of experience in the pharmaceutical industry coupled with deep knowledge and experience in the health care quality and quality measurement space.
Norris leads THCQ Consulting in partnering with biopharmaceutical clients to optimize the value delivered in addressing their payer and provider (including pharmacy) customers’ pain points, with patients’ needs at the center. Through Norris’ leadership, THCQ Consulting helps deliver quality strategy as a vital complement to existing late-stage clinical development, medical affairs, market access, and brand strategy.
Prior to founding THCQ Consulting and starting his affiliation with Discern, Norris served as Vice President of Strategic Alliances and Measure Implementation for the Pharmacy Quality Alliance (PQA). In this role, Norris led PQA’s efforts to develop and maintain relationships at the regional, state, and federal level with government agencies, commercial payers, providers, and pharmacies to further PQA’s quality measure development and implementation efforts.
Prior to PQA, Norris served with Janssen for 12 years. His most recent position at Janssen was as Director, Health Care Quality, Neuroscience, and Infectious Diseases within the Strategic Customer Group, Johnson & Johnson Health Care Systems Inc., where he focused on the overarching quality and value-based care reimbursement direction in the United States and its implications for key customer segments and business strategy. Over a 15-year period, Norris held a variety of positions with increasing responsibility at Pfizer, Purdue Pharma, and Janssen in phase 2–4 clinical development and investigator-initiated research in the therapeutic areas of psychiatry and pain.
Areas of Expertise
- Wide expertise in the pharmaceutical industry across clinical development, medical affairs, market access, health care quality, and policy
- Strategic evaluation of the role of quality measurement, value-based performance programs, and realigned stakeholder incentives on biopharmaceutical client key customer segments and company strategy
- Quality measure development and use of measures in public and commercial programs
- Two-Year Graduate Certificate, Health Policy, Thomas Jefferson University School of Population Health
- PharmD – University of Michigan College of Pharmacy
- PhD, Pharmaceutical Chemistry – University of California San Francisco School of Pharmacy, Graduate Division
Honors and Awards
- Pharmaceutical Research and Manufacturers of America “We Work For Health Champion” Award
- University of California San Francisco Chancellor Award for Dr. Martin Luther King, Jr., Leadership